Amarantus BioSciences Inc., of Sunnyvale, Calif., said it secured more than $1.1 million in funding through two separate transactions. The firm issued a convertible promissory note to an undisclosed investor in the principal amount of $600,000 and, in an unrelated equity financing deal with an institutional fund, settled more than $500,000 in accounts payable.